Total Payments
$2,403
2024 Payments
$716.90
Companies
16
Transactions
132
Medicare Patients
969
Medicare Billing
$89,284
Payment Breakdown by Category
Food & Beverage$2,357 (98.0%)
Education$46.91 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,357 | 131 | 98.0% |
| Education | $46.91 | 1 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $606.49 | 34 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $302.23 | 18 | $0 (2024) |
| Alkermes, Inc. | $259.09 | 17 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $236.53 | 8 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $178.04 | 10 | $0 (2024) |
| Indivior Inc. | $154.11 | 11 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $154.11 | 8 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $97.94 | 5 | $0 (2021) |
| ABBVIE INC. | $92.94 | 4 | $0 (2024) |
| ITI, Inc. | $79.05 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $716.90 | 31 | Supernus Pharmaceuticals, Inc. ($205.55) |
| 2023 | $480.22 | 26 | Janssen Pharmaceuticals, Inc ($147.41) |
| 2022 | $269.38 | 18 | Indivior Inc. ($66.50) |
| 2021 | $231.53 | 13 | Janssen Pharmaceuticals, Inc ($98.35) |
| 2020 | $101.78 | 6 | Janssen Pharmaceuticals, Inc ($38.44) |
| 2019 | $318.42 | 20 | Janssen Pharmaceuticals, Inc ($95.53) |
| 2018 | $206.99 | 13 | Vanda Pharmaceuticals Inc. ($62.31) |
| 2017 | $78.24 | 5 | Lundbeck LLC ($35.71) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Neuropsychiatry | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $15.75 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $21.76 | General |
| 08/05/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Neuroscience | ||||||
| 06/28/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: CNS | ||||||
| 06/25/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/18/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Neuroscience | ||||||
| 05/28/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/08/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 05/08/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 04/05/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Neurology | ||||||
| 04/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 04/03/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Neuroscience | ||||||
| 03/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $37.71 | General |
| Category: Neurology | ||||||
| 03/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Neuroscience | ||||||
| 03/01/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: BH | ||||||
| 02/26/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Neuroscience | ||||||
| 02/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 02/07/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: CNS | ||||||
| 02/05/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: PSYCHIATRY | ||||||
| 01/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Neuropsychiatry | ||||||
| 01/30/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 194 | 583 | $47,215 | $20,674 |
| 2022 | 5 | 223 | 682 | $55,785 | $25,259 |
| 2021 | 6 | 303 | 643 | $53,784 | $22,842 |
| 2020 | 7 | 249 | 509 | $55,969 | $20,509 |
Total Patients
969
Total Services
2,417
Medicare Billing
$89,284
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 117 | $20,890 | $9,788 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 157 | $18,402 | $9,033 | 49.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 42 | 127 | $3,175 | $914.37 | 28.8% |
| J1631 | Injection, haloperidol decanoate, per 50 mg | Office | 2023 | 16 | 169 | $3,452 | $801.65 | 23.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 13 | 13 | $1,296 | $136.32 | 10.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 127 | $22,711 | $10,614 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 178 | $20,615 | $9,942 | 48.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 20 | 20 | $4,352 | $2,205 | 50.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 47 | 174 | $4,350 | $1,534 | 35.3% |
| J1631 | Injection, haloperidol decanoate, per 50 mg | Office | 2022 | 18 | 183 | $3,757 | $963.70 | 25.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 104 | 217 | $25,817 | $12,530 | 48.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 62 | $10,985 | $5,601 | 51.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 12 | 12 | $3,378 | $1,728 | 51.2% |
| J1631 | Injection, haloperidol decanoate, per 50 mg | Office | 2021 | 24 | 138 | $2,860 | $1,044 | 36.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 58 | 136 | $3,400 | $984.20 | 28.9% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 63 | 78 | $7,344 | $955.07 | 13.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 112 | 247 | $30,202 | $11,999 | 39.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 22 | 43 | $5,852 | $3,305 | 56.5% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 13 | 31 | $5,425 | $1,989 | 36.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 17 | 17 | $8,041 | $1,966 | 24.4% |
| J1631 | Injection, haloperidol decanoate, per 50 mg | Office | 2020 | 19 | 84 | $1,785 | $502.67 | 28.2% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 29 | 31 | $3,264 | $386.60 | 11.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 37 | 56 | $1,400 | $361.86 | 25.8% |
About Dr. Ayodele Ogunfowora, M.D
Dr. Ayodele Ogunfowora, M.D is a Psychiatry healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073578506.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ayodele Ogunfowora, M.D has received a total of $2,403 in payments from pharmaceutical and medical device companies, with $716.90 received in 2024. These payments were reported across 132 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,357).
As a Medicare-enrolled provider, Ogunfowora has provided services to 969 Medicare beneficiaries, totaling 2,417 services with total Medicare billing of $89,284. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Columbia, SC
- Active Since 04/18/2006
- Last Updated 11/08/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073578506
Products in Payments
- INVEGA SUSTENNA (Drug) $574.20
- INGREZZA (Drug) $302.23
- Qelbree (Drug) $205.55
- ARISTADA (Drug) $192.05
- PERSERIS (Drug) $154.11
- REXULTI (Drug) $133.10
- VRAYLAR (Drug) $108.94
- CAPLYTA (Drug) $79.05
- UZEDY (Drug) $74.88
- ABILIFY MAINTENA (Drug) $70.51
- Aristada 441 mg (Drug) $51.90
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $48.81
- AUSTEDO (Drug) $45.33
- ABILIFY ASIMTUFII (Drug) $41.38
- Fanapt (Drug) $38.43
- LATUDA (Drug) $37.55
- Auvelity (Drug) $36.11
- HETLIOZ (Drug) $35.63
- SPRAVATO (Drug) $32.29
- QELBREE (Drug) $30.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Columbia
Dr. Meera Narasimhan, M.d, M.D
Psychiatry — Payments: $57,045
Psychiatry $57,045
Dr. Joseph Parks, M.d, M.D
Psychiatry — Payments: $53,504
Psychiatry $53,504
Agara Reddy, Md, MD
Psychiatry — Payments: $15,068
Psychiatry $15,068
Deborah Leverette, Md Mph, MD MPH
Psychiatry — Payments: $12,750
Psychiatry $12,750
Gariane Gunter, M.d, M.D
Psychiatry — Payments: $11,480
Psychiatry $11,480
Dr. Nioaka Campbell, M.d, M.D
Psychiatry — Payments: $10,898
Psychiatry $10,898